Is the Gut the "Sweet Spot" for the Treatment of Diabetes?

Gastric Bypass Improves β-Cell Function and Increases β-Cell Mass in a Porcine Model

(2014) Andreas Lindqvist et al.   DIABETES

FXR is a molecular target for the effects of vertical sleeve gastrectomy

(2014) Karen K. Ryan et al.   NATURE

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes

(2013) Danna M. Breen et al.   DIABETES

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass

(2013) M. Shah et al.   DIABETES

Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass

(2013) Kirstine N. Bojsen-Møller et al.   DIABETES

Duodenal-Jejunal Bypass and Jejunectomy Improve Insulin Sensitivity in Goto-Kakizaki Diabetic Rats Without Changes in Incretins or Insulin Secretion

(2013) S. Salinari et al.   DIABETES

Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment

(2013) S. R. Kashyap et al.   DIABETES CARE

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

(2013) Carsten Dirksen et al.   DIABETOLOGIA

Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia

(2013) Sayeed Ikramuddin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Surgical control of obesity and diabetes: The role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis

(2013) Rajesh T. Patel et al.   Obesity

Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance

(2013) Serenella Salinari et al.   PLoS One

Heterotopic pancreas in excluded stomach diagnosed after gastric bypass surgery

(2013) Marta Guimarães et al.   BMC Surgery

Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese Subjects

(2012) Serenella Salinari et al.   ANNALS OF SURGERY

Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes

(2012) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes

(2012) Geltrude Mingrone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Duodenal-jejunal bypass protects GK rats from β-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1

(2011) Madeleine Speck et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Gastrointestinal hormones and the regulation of β-cell mass

(2010) Jeremy A. Lavine et al.   Annals of the New York Academy of Sciences

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

(2010) K. J. Hare et al.   DIABETES

Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of β-cells in Goto-Kakizaki rats

(2010) Zhen Li   WORLD JOURNAL OF GASTROENTEROLOGY

Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis

(2008) F. Rubino   DIABETES CARE